Top Chinese Retailers Slash iPhone Prices
Two major Chinese retailers have slashed prices on Apple Inc.'s latest iPhones as demand for the device flags in the world's largest smartphone market.
Shows from Bloomberg
India Secretary of Finance Subhash Chandra Garg discusses foreign investment, the strength of the rupee, and India's economy ahead of elections in the nation.
Abhinav Davuluri, analyst at Morningstar, examines second-quarter results from Micron Technology Inc.
Paul Matteis, managing director of biotechnology equity research at Stifel, discusses Biogen Inc. halting research on its experimental Alzheimer's drug.
Diamond Offshore Drilling CEO Marc Edwards discusses market competition in deepwater drilling exclusively with Bloomberg's Alix Steel on 'Bloomberg: Daybreak Americas.'
Bruce Flatt, chief executive officer at Brookfield Asset Management, and Howard Marks, co-founder at Oaktree Capital, discuss the background of Brookfield's purchase of a majority stake in Oaktree Capital.
Bruce Flatt, chief executive officer at Brookfield Asset Management, and Howard Marks, co-founder at Oaktree Capital, discuss the background of Brookfield's purchase of a majority stake in Oaktree Capital and how the deal could impact the industry.
Rabobank Head of FX Strategy Jane Foley examines sterling as the Brexit deadline nears and the Bank of England holds interest rates steady.
Bloomberg's Jason Kelly discusses actions at Deutsche Bank.
Ben Mandel, global strategist at JPMorgan Asset Management, and Bloomberg Intelligence's Ira Jersey, discuss Federal Reserve monetary policy and what it may mean for investing.
The Bank of England voted unanimously to hold interest rates steady as companies begin to trigger plans for a no-deal Brexit.
Norges Central Bank Governor Oystein Olsen discusses the central bank's second hike of interest rates since September, while signaling more tightening to come.
Biogen Inc. announced it was halting research on its experimental Alzheimer's drug as it was unlikely to be effective. Bloomberg Opinion columnist Max Nisen reports on "Bloomberg Daybreak: Americas.
In "Single Best Chart," Bloomberg Intelligence's Ira Jersey examines how U.S. inflation expectations are impacting Federal Reserve policy.
Jeff Jonas, chief executive officer at Sage Therapeutics, discusses Food and Drug Administration approval of the company's first postpartum drug, the price of the drug, and products in their drug pipeline.
Wolfango Piccoli, co-president of political and policy risk advisory at Teneo Intelligence, discusses his view that time gives Chinese President Xi Jinping the upper hand in trade negotiations with U.S. counterpart Donald Trump.
Michele Geraci, undersecretary in Italy's Economic Development Ministry, discusses plans to sign a preliminary agreement with China which would see Italy open its ports as a European point of entry for China's "Belt and Road" initiative.
John Bilton, head of global multi-asset strategy at JPMorgan Asset Management. discusses the Federal Reserve's balance sheet normalization and its impact on Treasury yields.
Isabelle Millat, head of sustainable investments solutions global markets at Societe Generale, examines the reasons why investors are increasingly turning to ESG funds.
Patrick Armstrong, chief investment officer at Plurimi Wealth, and Bloomberg's Ksenia Galouchko discuss analyst expectations for a retreat later this year from the rally in European equities.
Xi Jinping is expected to arrive in Rome today. China's President and the Italian government are said to sign a controversial "memorandum of understanding" on the Belt & Road Initiative. This would make Italy the first G-7 country to sign in defia...
John Roe, head of multi asset funds at Legal & General Investment Management, discusses the European rates curve, why it is a strong predictor of returns, why he's bullish on European equities and why there is opportunity in the contrarian trade.